Stock comparison
LeMaitre Vascular
Pfizer
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
PFE
Pfizer
Market cap
$147.62B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | PFE | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 55C | LMAT |
| Benjamin Graham | 89A | 53C | LMAT |
| Philip Fisher |
Side-by-side metrics
| Metric | LMAT | PFE |
|---|---|---|
| Market cap | $2.23B | $147.62B |
| P/E (TTM) | 37.1x | 19.2x |
| EV/EBIT | 36.6x | 13.4x |
| ROIC (TTM) | 9.43% | 7.97% |
| Gross margin | 72.39% | 69.35% |
| Net margin | 24.35% | 11.83% |
| Revenue CAGR 5y | 12.75% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- EPS CAGR 5y19.04%vs -23.42%+181%
- Revenue CAGR 5y12.75%vs -6.33%+150%
- Net margin24.35%vs 11.83%+51%
- Debt / Equity0.5xvs 0.7x
More like PFE
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.